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Abstract
Background & Aims—High-resolution microendoscopy is an optical imaging technique with 
the potential to improve the accuracy of endoscopic screening for esophageal squamous neoplasia. 
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Although these microscopic images can readily be interpreted by trained personnel, quantitative 
image analysis software could facilitate the use of this technology in low-resource settings. In this 
study we developed and evaluated quantitative image analysis criteria for the evaluation of 
neoplastic and non-neoplastic squamous esophageal mucosa.
Methods—We performed image analysis of 177 patients undergoing standard upper endoscopy 
for screening or surveillance of esophageal squamous neoplasia, using high-resolution 
microendoscopy, at 2 hospitals in China and 1 in the United States from May 2010 to October 
2012. Biopsies were collected from imaged sites (n=375); a consensus diagnosis was provided by 
2 expert gastrointestinal pathologists and used as the standard.
Results—Quantitative information from the high-resolution images was used to develop an 
algorithm to identify high-grade squamous dysplasia or invasive squamous cell cancer, based on 
histopathology findings. Optimal performance was obtained using mean nuclear area as the basis 
for classification, resulting in sensitivities and specificities of 93% and 92% in the training set, 
87% and 97% in the test set, and 84% and 95% in an independent validation set, respectively.
Conclusions—High-resolution microendoscopy with quantitative image analysis can aid in the 
identification of esophageal squamous neoplasia. Use of software-based image guides may 
overcome issues of training and expertise in low-resource settings, allowing for widespread use of 
these optical biopsy technologies.
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Introduction
There is an urgent global need to improve early diagnosis of esophageal squamous cell 
neoplasia (ESCN).1,2 The five-year survival rate of ESCN in the United States is only 19%, 
primarily because diagnosis is often at an advanced, incurable stage.3 In low-resource 
settings, the five-year survival is much lower; for example, in Golestan Province, Iran, it is 
3.4%.4 At present, the current standard of care for endoscopic screening is Lugol’s 
chromoendoscopy (LCE) with targeted biopsy of areas that do not retain dye.5 The 
sensitivity of LCE is >95%, but specificity is poor (<65%).6,7 Areas of inflammation often 
appear indistinguishable from superficially invasive carcinoma, leading to high false 
positive rates. Confocal microendoscopy, a high-resolution imaging technique, has 
revolutionized endoscopic surveillance for neoplasia by allowing detection at the subcellular 
level.8 When confocal imaging is paired with LCE, accuracy rates have been shown to 
approach 95% with dramatic improvement in specificity.9 However, existing platforms are 
expensive ($150,000–$300,000) and available only in a handful of tertiary centers.
Thus, there remains an essential need for easily accessible, complementary high-resolution 
imaging technologies that can improve accuracy of LCE by enhancing specificity, and 
reducing the number of biopsies needed for accurate patient diagnosis. Ideally, low cost 
imaging platforms should be robust, accurate, and reproducible when used in low-resource 
settings where there is often a shortage of healthcare providers and frequent biopsies of 
suspected areas are not feasible because of the scarcity and high cost of pathology services. 
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We recently developed a fiber-optic high-resolution microendoscope (HRME) that provides 
images of the surface epithelium with similar resolution to confocal endomicroscopy, but 
with significantly reduced system complexity and cost.10 The cost-of-goods to assemble an 
HRME system is less than $3,500, including the cost of the re-usable fiber optic probe. For a 
detailed description of the HRME, see the Supplementary Materials. Recent studies 
conducted with the HRME demonstrated that sub-cellular resolution morphology can be 
used to detect neoplastic lesions in patients with Barrett’s esophagus, breast, cervical and 
oral carcinoma.11–16
HRME images can be interpreted by trained clinical personnel at the point-ofcare.15,16 
However, quantitative image analysis may provide more objective results and facilitate use 
of this technology in low-resource settings where trained personnel are not always available. 
The goal of the present study was to develop quantitative HRME image analysis criteria for 
delineation of neoplastic and non-neoplastic squamous esophageal mucosa.
Materials and Methods
Patients
Study participants previously scheduled to undergo screening for ESCN or surveillance for 
known squamous cell dysplasia underwent standard high-definition white light upper 
endoscopy (HD-WLE) with LCE. Written informed consent was obtained. The study was 
reviewed and approved by the Institutional Review Boards at The First Hospital of Jilin 
University (Changchun, China), The Cancer Institute at The Chinese Academy of Medical 
Sciences (Beijing, China), The Mount Sinai Medical Center (New York, NY), and Rice 
University (Houston, TX).
The endoscopist recorded the location, level, and clinical impression of each Lugol’s 
unstained area. Lugol’s unstained areas that were indeterminate or suspicious for neoplasia 
were further interrogated with an HRME. Prior to HRME imaging at each site, a topical 
solution (average 4.77 ml; range 1–10 ml) of 0.01% proflavine (P2508, Sigma- Aldrich, St. 
Louis, MO) in sterile phosphate buffered saline was applied to the esophageal surface using 
a spray catheter. Proflavine, which was used under an Investigational New Drug (IND) 
application from the Food and Drug Administration (IND 102 217), is a fluorescent contrast 
agent which stains cell nuclei. Proflavine absorbs light strongly at 445 nm, and it emits light 
with a peak around 510 nm. Following proflavine application, the HRME probe was inserted 
through the biopsy channel and the distal tip placed in gentle contact with the mucosa. 
Nuclei stained with proflavine were clearly visible for 5–10 minutes following application 
of proflavine. At each site between 1 and 113 video sequences of 1–3 seconds duration were 
acquired and stored as movie files so that an individual frame free of motion artifact could 
be subsequently be selected for analysis. The number of video sequences collected at a given 
site was determined by the endoscopist’s clinical judgment. The median number of video 
sequences collected per site was 4. HRME images were also obtained from two Lugol’s 
stained (“normal”) areas from each patient to determine the device’s false negative rate. At 
each site imaged, the probe was used to make a superficial dimple to “mark” the imaged 
area for biopsy. Each imaged site was biopsied and submitted for routine histologic 
diagnosis. Slides were reviewed by two expert gastrointestinal pathologists (AP, SD) 
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blinded to HD-WLE, LCE, and HRME endoscopic interpretations. Diagnosis was performed 
using standard criteria; samples were divided into the following categories: normal, 
inflammation, low-grade dysplasia (LGD), high-grade dysplasia (HGD), or cancer.17
Quality control and frame selection
Videos acquired with the HRME were reviewed for quality control (QC) by three observers 
(RRK, MP, MAP) blinded to clinical impression and pathologic diagnosis. First, one 
reviewer (MP) identified a single representative image frame with minimal motion artifact 
from each video sequence. Selected images were reviewed and those with 50% or more of 
the field of view (FOV) obscured by motion artifact, poor focus, or debris at the tip of the 
fiber bundle were excluded. At each site, a single representative image with good visual 
image quality was selected by reviewer consensus. In the case of a heterogeneous set of 
candidate images for a given site, the reviewers selected the image that appeared to 
correspond to the worst diagnosis.
Image analysis
Images were processed to extract features of potential use for classification (Figure 1). 
Images were first analyzed to exclude regions which were too dim for analysis due to 
uneven contact of the distal fiber tip with the epithelium, or saturated due to the presence of 
debris at the probe tip. Regions to be excluded were identified by applying a low-pass filter 
to highlight homogeneous regions of similar intensity and then thresholding to reject overly 
dim or saturated areas. The region of interest (ROI) was then defined as the entire field of 
view minus the excluded areas. Following ROI selection, Gaussian spatial filtering was 
applied to remove the background pattern of the HRME fiber bundle. Morphologic image 
processing and thresholding were used to segment nuclei. Once a threshold was determined 
by the histogram-based thresholding method, nuclear and cytoplasmic regions were 
separated by the threshold.
Following segmentation, the mean, standard deviation, and coefficient of variation of the 
following features were calculated for each image: nuclear size, nuclearto-cytoplasmic area 
ratio (N/C ratio), nearest internuclear distance, nuclear eccentricity, nuclear solidity, and 
major axis of the ellipse best approximating each nucleus.
All steps shown in Figure 1 (ROI selection, filtering, segmentation, and feature calculation) 
are fully automated and require 3.2 seconds processing for a single image.
Image classification
Extracted features were used to develop and evaluate an algorithm to classify whether each 
site contained neoplastic (HGD, cancer) or non-neoplastic tissue (normal, inflammation, 
LGD). The decision to draw the line between LGD and HGD was consistent with confocal 
microendoscopic classification criteria. LGD was considered non-neoplastic as it is 
associated with a low rate of progression to HGD or ESCN and is treated differently than 
HGD in a clinical setting. LGD is followed with serial endoscopies, while HGD can be 
treated with radiofrequency ablation (RFA) and/or endoscopic mucosal resection 
(EMR).17,18 Data obtained at The First University Hospital and The Mount Sinai Medical 
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Center were randomly divided into a training set to develop and optimize the algorithm, and 
an independent test set to estimate algorithm performance. Approximately 50% of the 
images were randomly assigned to the training set and 50% to the test set. Randomization 
was repeated until the proportion of neoplastic sites was approximately the same in the 
training and test sets. All images from a single patient were assigned to either the training or 
the test set. The data obtained at The Cancer Institute at The Chinese Academy of Medical 
Sciences were assigned to an independent validation set.
Two-class linear discriminant analysis was used to develop a classification algorithm. For 
details, see the Supplementary Materials. Image classification is fully automated and 
requires 0.3 seconds. Thus, the total time required to fully process and classify a single 
image is 3.5 seconds.
Results
Subject information – patients and sites
215 subjects were enrolled in the study; images with corresponding pathology results were 
available from 448 sites in 194 patients. Of these 448 sites, images from 65 sites were 
excluded due to QC issues (motion artifact, poor focus, or debris). Images from 8 sites were 
excluded because reviewers did not reach consensus on a representative image. The final 
data set for analysis consisted of images from 375 sites in 177 patients. Table 1 shows the 
histological diagnosis of measured sites in the final data set. The data obtained at The First 
University Hospital and The Mount Sinai Medical Center were randomly separated into 
training and test sets; 104 sites from 54 patients were assigned to the training set and 104 
sites from 45 patients were assigned to the test set (Table 1). The remaining data obtained at 
The Cancer Institute at The Chinese Academy of Medical Sciences were assigned to an 
independent validation set which consisted of 167 sites from 78 patients (Table 1).
Quantitative classification performance
Quantitative image features were calculated using automated image analysis. Figure 2 
illustrates bar graphs of the mean quantitative image feature values for neoplastic and non-
neoplastic tissue in the training set. P values were obtained with the Mann-Whitney U test. 
The average feature values of non-neoplastic were significantly different from those of 
neoplastic for all features.
A two-class linear discriminant algorithm was developed to separate neoplastic and non-
neoplastic tissue using each of these features. The single best performing feature was found 
to be the mean nuclear area. Figure 3(a) depicts a scatter plot of this feature for each site in 
the training set. The decision line associated with the classifier is shown as a straight line; 
the algorithm results in a sensitivity of 93% and a specificity of 92%. Figure 3(b) and 3(c) 
illustrate this feature for each site in the test and validation sets; the decision line developed 
using the training set is also shown. Applying the algorithm to the test set results in a 
sensitivity of 87% and a specificity of 97%, and applying it to the validation set results in a 
sensitivity of 84% and a specificity of 95%. Figure 4 shows the associated receiver operating 
characteristic (ROC) curves. The area under the ROC curve is 0.92 in the training set, 0.95 
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in the test set, and 0.93 in the validation set. The addition of multiple features did not 
improve performance.
Discussion
This study assessed the feasibility of quantitative analysis of HRME images for detection of 
ESCN. Using mean nuclear area, non-neoplastic and neoplastic esophageal squamous 
epithelium could be discriminated with a sensitivity of 87% and a specificity of 97% in the 
test set and 84% and 95% in the validation set compared to histopathology. For comparison, 
the sensitivity and specificity of LCE were 100% and 51% in the training set, 93% and 55% 
in the test set, and 100% and 54% in the validation set, respectively; HRME imaging is 
associated with substantially improved specificity relative to LCE. The use of quantitative 
image analysis potentially reduces the need to train endoscopists to interpret HRME images. 
Visual interpretation is subject to interand intra-observer variability which may be reduced 
with digital image analysis.19 This may prove particularly useful in low-resource settings 
where experienced personnel are limited.
Given the limitations of existing screening approaches, the high cost of current high-
resolution platforms, and the uniformly poor prognosis of invasive ESCN, there is a great 
need for more accurate and widely available technologies, particularly in low-resource 
countries with high rates of ESCN. The low specificity of endoscopic screening is a 
particular barrier in low-resource settings where pathology services are limited. For 
example, in Kenya there are approximately 40 pathologists in the country and the majority 
practice in Nairobi.20 Moreover, in low-resource settings the cost of getting one biopsy 
processed and read is often greater than the cost of an endoscopic examination; for example, 
at Tenwek hospital in Kenya, these costs are $35 and $25, respectively. Thus, a robust, low-
cost method of detecting squamous cell neoplasia at an early, resectable stage with fewer 
biopsies could markedly improve existing endoscopic screening, surveillance and treatment. 
In the validation set reported here, 68 of 87 positive findings by LCE were falsely positive 
by histology; the improved specificity of HRME imaging could reduce the large number of 
false positives.
While not a commercial product, the $3,500 cost-of-goods of the HRME system suggests it 
could be affordable for use in low-resource settings. Over the 29 month duration of this 
study, five HRME systems were used without need for on-site technical support or 
maintenance. The HRME fiber optic probe is reusable; the only maintenance required is 
polishing the fiber bundle which was performed on site after the probe had been used for 
60–75 procedures. The cost of proflavine was less than 1 penny per procedure. The HRME 
must be used in conjunction with endoscopy, but new LED-based endoscopes that reduce 
the cost by more than 2/3 of current systems are being introduced commercially in China.21
The contrast agent proflavine is an acriflavine derivative that has a long history of safe use 
as a topical antiseptic, and has been used for fluorescence imaging in Europe, Asia and 
Australia with no reports of adverse events. In our experience of >300 subjects imaged to 
date with proflavine, no adverse events were noted.
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The strengths of this study include the fact that it was a multi-center, international, in vivo 
study with data from the first two clinical sites randomized to a training set for algorithm 
development and a separate test set to evaluate the performance of the algorithm relative to 
the standard of histopathology. In addition, performance of the algorithm was assessed in an 
independent validation set acquired in a different clinical setting than the training and test 
sets.
A limitation of this study is that image analysis was not performed in real time; instead, 
images were analyzed post-hoc, following acquisition. Two technical limitations currently 
prevent real-time analysis. (1) Quality control and frame selection are currently performed 
manually after the imaging session has been completed. With recent advances in automated 
quality control and frame selection we will now be able to perform these functions 
automatically within 1 minute of data collection, enabling “near real-time” analysis during 
the imaging session. (2) The current algorithm requires 3.5 seconds to process and classify 
an image, which does not permit real-time processing at 15 frames/second. Further 
improvements in processing speed may enable live display with automated frame-by-frame 
analysis.
Alternatively, the algorithm developed here could be used to enable computer assisted visual 
image analysis. Figure 5 shows an example of how results of the image analysis presented 
here can guide development of visual image interpretation guidelines to assist endoscopists 
in classifying HRME images. Mean nuclear area was found to be the best performing image 
feature, with samples classified as neoplastic if mean nuclear area exceeds 180 µm2 (Fig. 
3a); this corresponds to a mean nuclear diameter of 15.1 µm assuming circular nuclei. As a 
simple way to extend this approach to visual image interpretation, we added a row of 15.1 
µm diameter dots to the top of each HRME image; in addition, we superimposed a grid with 
lines spaced 19.4 µm apart to facilitate estimation of nuclear size across the image. 
Observers are presented an image with the dots and grid superimposed and asked to visually 
assess whether most nuclei are larger than 15.1 µm in diameter; if so, then the site is 
diagnosed as neoplastic. The visual image interpretation guide is now embedded in the 
HRME imaging software and superimposed on an image window to assist clinicians in 
identifying neoplastic lesions in real-time at the time of endoscopy.
In this study, a representative image for each site was selected manually by reviewer 
consensus. While we did not attempt to quantify the heterogeneity of images from a given 
site in this analysis, we note that more heterogeneity was observed in images from unstained 
lesions that were in fact positive by histopathology than from unstained lesions that were 
negative by histopathology.
While preliminary, the high accuracy and specificity of quantitative analysis of HRME 
images demonstrated here suggest that this technique could potentially be used to more 
accurately and selectively target biopsy location. The ability to analyze images 
quantitatively may increase utilization of such a technology, particularly in rural or 
community-based settings with limited access to trained clinicians. Additionally, because of 
improved specificity, such a technology may reduce the number of biopsies needed for 
accurate patient diagnosis in low-resource settings where pathology processing and reading 
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costs are a disproportionately large component of the total cost of patient evaluation and 
diagnosis and there may be limited access to standard histologic analysis. Lastly, the ability 
to delineate normal from neoplastic mucosa in real-time, if this can be achieved, may 
enhance endoscopic margin detection, enabling greater accuracy for complete resection by 
minimally-invasive endoscopic therapies such as EMR and RFA, a less costly and less 
morbid alternative to surgical esophagectomy.22 The ability of endoscopists to interpret the 
HRME images in real time with the assistance of the image analysis for ESCN is being 
studied in a prospective, international, multi-center trial.
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Refer to Web version on PubMed Central for supplementary material.
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EMR endoscopic mucosal resection
ESCN esophageal squamous cell neoplasia
FOV field of view
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Figure 1. 
Quantitative image analysis process. 1) An ROI (a) is selected automatically, excluding 
image regions which are saturated (b) or too dim (c). 2) Fiber pattern is removed using 
Gaussian filtering. 3) Nuclei are segmented. 4) Quantitative image features are calculated 
(e.g. nearest internuclear distance).
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Figure 2. 
Bar graphs indicating mean values of six quantitative image features (± one std. dev) for 
non-neoplastic and neoplastic sites in the training set. P-values were obtained using the 
Mann-Whitney U test.
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Figure 3. 
(a) Scatter plot of mean nuclear area for each measured site in the training set. The decision 
line which classifies sites as neoplastic or non-neoplastic with maximum accuracy is shown. 
(b) Scatter plot of mean nuclear area for each measured site in the test set. (c) Scatter plot of 
mean nuclear area for each measured site in the validation set. The decision line to classify 
sites as neoplastic or not using the training set is shown.
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Figure 4. 
ROC curves for linear discriminant analysis algorithm based on the single feature of mean 
nuclear area applied to data in (a) the training set, (b) the test set, and (c) the validation. The 
Q-points correspond to a sensitivity of 93% and a specificity of 92% in the training set (a), 
87% and 97% in the test set (b), and 84% and 95% in the validation set (c).
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Figure 5. 
Flow chart illustrating visually-guided image analysis algorithm. A row of 15.1 µm diameter 
reference dots was added to the top of each HRME image; in addition, a grid with lines 
spaced 19.4 µm apart was superimposed to facilitate estimation of nuclear size across the 
image. Each 15.1 µm diameter reference dot occupies approximately half the area of a single 
square in the grid. If most nuclei appear smaller than the 15.1 µm diameter reference dots, 
then the image is classified as non-neoplastic; otherwise it is classified as neoplastic.
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